Home | News & Analysis
Part B News
02/14/2022
The fourth phase of the Provider Relief Fund (PRF), originally planned to end in December, is still delivering payments to health care providers. The ongoing disbursement serves as a reminder to report your previous PRF payments and, if you want the feds to recalculate your most recent payment, make sure it’s worth an audit risk.
02/14/2022
State and federal prosecutors continue to extract sizable settlements from practices that allegedly submitted fraudulent claims for one type of service urine drug tests (UDT).
02/14/2022
Question: I read about a rheumatologist in Santa Fe restricting her patients who chose not to vaccinate against COVID-19 to telehealth because she considered their presence in the practice dangerous to her immunocompromised patients. Does this raise patient abandonment issues?
02/14/2022
Question: Which providers can perform and bill for psychological testing services described by CPT codes 96136-96139?
02/14/2022
Between 2016 and 2019, Medicare payments to laboratories for genetic tests quadrupled from $351 million to $1.41 billion. This sharp increase in spending on genetic testing is likely linked to excessive and fraudulent billing, according to a recent Office of Inspector General (OIG) report.
02/14/2022
CMS made its last major update to urine drug testing (UDT) codes in 2017, when it deleted three HCPCS codes for presumptive drug tests (G0477-G0479) and adopted three new CPT codes (80305-80307) that picked up the outgoing G codes’ descriptors.

Login

User Name:
Password:
Welcome to the new Part B News Online. If you are a returning user having trouble logging in, please click here.
Back to top